期刊中文名:臨床(chuang)藥理學進展(zhan)與應用ISSN:1179-1438
該雜(za)志國際簡(jian)稱:CLIN PHARMACOL-ADV A,是(shi)由出(chu)版商Dove Medical Press出(chu)版的(de)(de)(de)一(yi)本(ben)致力于(yu)發(fa)布--研(yan)(yan)究(jiu)新(xin)成果(guo)的(de)(de)(de)的(de)(de)(de)專(zhuan)業學(xue)術期刊(kan)。主要發(fa)表刊(kan)登有(you)創見(jian)的(de)(de)(de)學(xue)術論(lun)文(wen)文(wen)章、行業最(zui)新(xin)科研(yan)(yan)成果(guo),扼要報(bao)道階段性研(yan)(yan)究(jiu)成果(guo)和(he)重(zhong)要研(yan)(yan)究(jiu)工(gong)作的(de)(de)(de)最(zui)新(xin)進展(zhan),選載(zai)對學(xue)科發(fa)展(zhan)起指導作用的(de)(de)(de)綜述(shu)與專(zhuan)論(lun),促(cu)進學(xue)術發(fa)展(zhan),為廣大讀者服務。該刊(kan)是(shi)一(yi)本(ben)國際優秀雜(za)志,在國際上(shang)有(you)很高的(de)(de)(de)學(xue)術影響力。
《Clinical Pharmacology-advances And Applications》是一本(ben)以English為(wei)主的(de)開(kai)放獲取國際優(you)秀期(qi)刊(kan)(kan),中文名稱臨床藥理學進(jin)展(zhan)與應用,本(ben)刊(kan)(kan)主要出版(ban)、報道領(ling)域(yu)的(de)研(yan)究動(dong)態以及在(zai)該(gai)領(ling)域(yu)取得(de)的(de)各方面的(de)經(jing)驗和(he)科(ke)研(yan)成(cheng)果,介紹該(gai)領(ling)域(yu)有關本(ben)專(zhuan)業(ye)(ye)的(de)最新(xin)(xin)進(jin)展(zhan),探討行業(ye)(ye)發展(zhan)的(de)思(si)路(lu)和(he)方法(fa),以促進(jin)學術信息交流,提(ti)高行業(ye)(ye)發展(zhan)。該(gai)刊(kan)(kan)已被國際權(quan)威數據庫SCIE收錄,為(wei)該(gai)領(ling)域(yu)相關學科(ke)的(de)發展(zhan)起(qi)到了良好(hao)的(de)推動(dong)作用,也得(de)到了本(ben)專(zhuan)業(ye)(ye)人員的(de)廣(guang)泛認可。該(gai)刊(kan)(kan)最新(xin)(xin)影響(xiang)因(yin)子為(wei)3.1,最新(xin)(xin)CiteScore 指數為(wei)4.6。
Clinical Pharmacology Advances and Applications is an international academic journal dedicated to the field of clinical pharmacology. It publishes research articles on the mechanisms of action, pharmacodynamics, pharmacokinetics, pharmacogenomics, and personalized medicine of drugs in the human body. This journal aims to promote scientific advancements in clinical pharmacology and apply these advances to new drug development and patient treatment. The journal content not only includes basic research, but also involves practical applications such as clinical trial design, drug safety evaluation, and drug efficacy optimization.
Magazines play an important role in the field of clinical pharmacology, providing researchers with a platform to publish the latest research findings and evidence-based clinical decision support for doctors and pharmacists. The characteristics of the journal lie in its interdisciplinary research scope and in-depth exploration of key issues in the process of new drug development, which are crucial for improving the safety and effectiveness of drug therapy.
按JIF指標學(xue)科分區 |
學科:PHARMACOLOGY & PHARMACY
收錄子集:ESCI
分區:Q2
排名:126 / 354
百分位:
64.5% |
按JCI指標學科分(fen)區 |
學科:PHARMACOLOGY & PHARMACY
收錄子集:ESCI
分區:Q3
排名:232 / 354
百分位:
34.6% |
JCR分區:JCR分(fen)區來自科睿唯(wei)安公司,JCR是(shi)一個獨特的(de)多學(xue)科期(qi)(qi)刊(kan)評價(jia)工具,為(wei)唯(wei)一提供基于引文數據(ju)的(de)統計信息(xi)的(de)期(qi)(qi)刊(kan)評價(jia)資(zi)源。每年(nian)發(fa)布的(de)JCR分(fen)區,設(she)置了(le)254個具體學(xue)科。JCR分(fen)區根據(ju)每個學(xue)科分(fen)類按(an)照期(qi)(qi)刊(kan)當年(nian)的(de)影響因子高(gao)低(di)將期(qi)(qi)刊(kan)平均(jun)分(fen)為(wei)4個區,分(fen)別為(wei)Q1、Q2、Q3和Q4,各(ge)占25%。JCR分(fen)區中(zhong)期(qi)(qi)刊(kan)的(de)數量是(shi)均(jun)勻分(fen)為(wei)四個部(bu)分(fen)的(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Pharmacology (medical) | Q2 | 110 / 272 |
59% |
該(gai)雜志是(shi)一(yi)本(ben)國(guo)際優秀雜志,在國(guo)際上有較高(gao)的(de)學術(shu)影響(xiang)力,行業(ye)關注度很高(gao),已被(bei)國(guo)際權威數據(ju)庫SCIE收錄,該(gai)雜志在綜合(he)專(zhuan)(zhuan)業(ye)領(ling)域(yu)專(zhuan)(zhuan)業(ye)度認(ren)可很高(gao),對稿(gao)(gao)件內容的(de)創新(xin)性(xing)和學術(shu)性(xing)要求很高(gao),作為一(yi)本(ben)國(guo)際優秀雜志,一(yi)般(ban)投稿(gao)(gao)過審時(shi)(shi)間都較長,投稿(gao)(gao)過審時(shi)(shi)間平均 16 Weeks ,如(ru)果想(xiang)(xiang)投稿(gao)(gao)該(gai)刊要做好時(shi)(shi)間安排。版面費不祥。該(gai)雜志近兩(liang)年未被(bei)列入(ru)預警(jing)名單(dan),建議您投稿(gao)(gao)。如(ru)您想(xiang)(xiang)了解更多投稿(gao)(gao)政策及(ji)投稿(gao)(gao)方案(an),請咨詢(xun)客服。
若用(yong)戶需要(yao)出版服務(wu),請聯系(xi)出版商。